Xiong Jiang, Wang Li-jun, Guo Wei, Liu Xiao-ping, Yin Tai, Jia Xin, Ma Xiao-hui, Zhang Hong-peng, Xu Yong-le
Department of Vascular Surgery, General Hospital of People's Liberation Army, Beijing 100853, China.
Zhonghua Yi Xue Za Zhi. 2012 Feb 7;92(5):312-5.
To evaluate the early outcome of endovascular management of iatrogenic vascular injury (IVI).
From July 2002 to July 2010, 21 cases of IVI undergoing endovascular therapy were studied retrospectively. There were aorta injury (n = 2), peripheral artery injury (n = 11), visceral artery injury (n = 5), arteriovenous injury (n = 1) and venous injury (n = 2). And the procedures included endograft implantation (n = 15), intravascular embolization with coil (n = 4), combination of endovascular balloon intervention and percutaneous thrombin injection (n = 1) and balloon compression for hemostasis (n = 1).
Technical success was achieved in all patients. And clinical success, defined as arrested hemorrhage and hemodynamic stabilization, was obtained in 20 (95.2%) patients. There was one case of intra-operative mortality. After the procedure, there were cerebral infarction (n = 2) and partial renal infarction (n = 1). Among them, 19 patients received a median follow-up period of 23.9 months (range: 4 - 84 months). Only 1 patient with iliofemoral vein stent implantation developed stent collapse and thrombosis at Week 3. There were no other complications.
Endovascular therapy is an effective procedure in the management of different types of IVI. Despite its encouraging early results, the long-term outcomes require further follow-ups and observations.
评估医源性血管损伤（IVI）血管内治疗的早期疗效。
回顾性研究2002年7月至2010年7月期间接受血管内治疗的21例IVI患者。其中主动脉损伤2例，外周动脉损伤11例，内脏动脉损伤5例，动静脉损伤1例，静脉损伤2例。治疗方法包括植入血管内支架（15例）、弹簧圈血管内栓塞（4例）、血管内球囊干预联合经皮注射凝血酶（1例）以及球囊压迫止血（1例）。
所有患者技术操作均成功。20例（95.2%）患者取得临床成功，即出血停止且血流动力学稳定。术中死亡1例。术后发生脑梗死2例，部分肾梗死1例。其中19例患者接受了中位时间为23.9个月（范围：4 - 84个月）的随访。仅1例髂股静脉支架植入患者在第3周出现支架塌陷和血栓形成。无其他并发症。
血管内治疗是处理不同类型IVI的有效方法。尽管早期结果令人鼓舞，但长期疗效仍需进一步随访观察。
